Targovax is invited to present at H.C. Wainwright 22[nd] Annual Global Investment Conference

On September 14, 2020 Targovax ASA, reported that Øystein Soug, CEO of Targovax, will present the company at H.C. Wainwright 22nd Annual Global Investment Conference on Wednesday 16 September, at 10:30am EDT / 4:30pm CET (Press release, Targovax, SEP 14, 2020, https://www.targovax.com/en/targovax-is-invited-to-present-at-h-c-wainwright-22nd-annual-global-investment-conference/ [SID1234565062]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

To access a live webcast of the presentation, please see link here. It can also be accessed through "Events" at www.targovax.com. A replay of the webcast will also be available following the event.

The presentation will be available to download at www.targovax.com after the event.

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!